Increased rates of obesity in first-presentation adults with mood disorders over the course of four-year follow-up

Journal of Affective Disorders

Volumn 109, Issue 1-2, 2008, Pages 127-131

  Taylor, Valerie ^a   Macdonald, Kathryn ^a   McKinnon, Margaret C ^a   Joffe, Russell T ^b   MacQueen, Glenda M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

First episode; Mood disorder; Morality; Obesity

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; UNDERWEIGHT; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BODY MASS INDEX; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MOOD DISORDERS; OBESITY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 43949133848     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.12.003     Document Type: Article

References (41)

1. Allison D.B., Fontaine K.R., Heo M., Mentore J.L., Cappelleri J.C., Chandler L.P., Weiden P.J., and Cheskin L.J. The distribution of body mass index among individuals with and without schizophrenia. J. Clin. Psychiatry 60 4 (1999) 215-220
2. American Psychiatric Association. Guidelines for the treatment of patients with bipolar disorder. Am. J. Psychiatry 159 suppl 4 (2002) 1-50
3. Basu R., Brar J.S., Chengappa K.N., John V., Parepally H., Gershon S., Schlicht P., and Kupfer D.J. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord. 6 4 (2004) 314-318
4. Carter F.A., Bulik C.M., and Joyce P.R. Direction of weight change in depression. J. Affect. Disord. 30 1 (1994) 57-60
5. Casey D.E. Dyslipidemia and atypical antipsychotic drugs. J. Clin. Psychiatry 65 Suppl 18 (2004) 27-35
6. Cassidy K., Kotynia-English R., Acres J., Flicker L., Lautenschlager N.T., and Almeida O.P. Association between lifestyle factors and mental health measures among community-dwelling older women. Aust. N. Z. J. Psychiatry 38 11-12 (2004) 940-947
7. Croft H., Settle Jr. E., Houser T., Batey S.R., Donahue R.M., and Ascher J.A. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin. Ther. 21 4 (1999) 643-658
8. Cuijpers P., de Graaf R., and van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J. Affect. Disord 79 1-3 (2004) 71-79
9. de Jonghe F., and Swinkles J.A. The safety of antidepressants. Drugs 43 52 (1992) 40-47
10. Dixon W.J. BMDP statistical software. Repeated Measure Models with Structured and Unstructured Covariance Matrices (1993), University of California Press, Los Angeles Release 7 [Module 5V]
11. Douketis J.D., Feightner J.W., Attia J., and Feldman W.F. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian task force on preventive health care. CMAJ 160 4 (1999) 513-525
12. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 7 5 (2005) 424-430
13. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
14. Heiskanen T.H., Niskanen L.K., Hintikka J.J., Koivumaa-Honkanen H.T., Honkalampi K.M., Haatainen K.M., and Viinamaki H.T. Metabolic syndrome and depression: a cross-sectional analysis. J. Clin. Psychiatry 67 9 (2006) 1422-1427
15. Jeffery R.W. Public health strategies for obesity treatment and prevention. Am. J. Health Behav. 25 3 (2001) 252-259
16. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Maser J., Solomon D.A., Leon A.C., Rice J.A., and Keller M.B. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 59 6 (2002) 530-537
17. Katzmarzyk P.T., and Ardern C.I. Overweight and obesity mortality trends in Canada, 1985-2000. Can. J. Public Health 95 1 (2004) 16-20
18. Leibowitz S.F., and Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 44 9 (1998) 851-864
19. Lu X.Y., Kim C.S., Frazer A., and Zhang W. Leptin: a potential novel antidepressant. Proc. Natl. Acad. Sci. U. S. A. 103 5 (2006) 1593-1598
20. Manson J.E., Stampfer M.J., Hennekens C.H., and Willett W.C. Body weight and longevity. A reassessment. JAMA 257 3 (1987) 353-358
21. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott S.T., and Lieberman J.A. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 80 1 (2005) 19-32
22. Michelson D., Amsterdam J.D., Quitkin F.M., Reimherr F.W., Rosenbaum J.F., Zajecka J., Sundell K.L., Kim Y., and Beasley Jr. C.M. Changes in weight during a 1-year trial of fluoxetine. Am. J. Psychiatry 156 8 (1999) 1170-1176
23. Musselman D.L., Betan E., Larsen H., and Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 54 3 (2003) 317-329
24. National Institutes of Health National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Bethesda (MD), U.S. Department of Health and Human Services. Ref Type: Report (1998)
25. Osby U., Brandt L., Correia N., Ekbom A., and Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 9 (2001) 844-850
26. Parikh S.V., and Lam R.W. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden. Can. J. Psychiatry 46 Suppl 1 (2001) 13S-20S
27. Raeder M.B., Bjelland I., Emil V.S., and Steen V.M. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J. Clin. Psychiatry 67 12 (2006) 1974-1982
28. Rockhill B., Newman B., and Weinberg C. Use and misuse of population attributable fractions. Am. J. Public Health 88 1 (1998) 15-19
29. Rothman K.J. Modern Epidemiology (1998), Little Brown and Company, Boston
30. Simon G.E., Von K.M., Saunders K., Miglioretti D.L., Crane P.K., van B.G., and Kessler R.C. Association between obesity and psychiatric disorders in the US adult population. Arch. Gen. Psychiatry 63 7 (2006) 824-830
31. Spitzer R., and Williams J. Structural clinical interview for DSM-IV. (1992), Biomedic Research Department, New York State Psychiatric Institute, New York
32. Statistics Canada. Canadian Community Health Survey, Version 1.1. (2004), Statistics Canada, Ottawa ON
33. Stunkard A.J., Fernstrom M.H., Price A., Frank E., and Kupfer D.J. Direction of weight change in recurrent depression. Consistency across episodes. Arch. Gen. Psychiatry 47 9 (1990) 857-860
34. Troiano R.P., Frongillo Jr. E.A., Sobal J., and Levitsky D.A. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int. J. Obes. Relat. Metab. Disord. 20 1 (1996) 63-75
35. Vanltallie T.B. Health Implication of overweight and obesity in the United States. Ann. Intern. Med. 103 (1985) 983-988
36. Vanltaillie T.B., and Lew E.A. Overweight and underweight. In: Lew E.A., and Gajewski J. (Eds). Medical Risks: Trends in Mortality by Age and Timed Elapsed. Praeger, New York (1990)
37. Windgassen K., Wesselmann U., and Schulze M.H. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology 33 3 (1996) 142-146
38. Wing R.R., Goldstein M.G., Acton K.J., Birch L.L., Jakicic J.M., Sallis Jr. J.F., Smith-West D., Jeffery R.W., and Surwit R.S. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 24 1 (2001) 117-123
39. World Health Organization. Physical status: the use and interpretation of anthropometry. World Health Organization. Report of a WHO Expert Committee. W. H. O. Tech. Rep. Ser. vol. 854 (1995) 1-452
40. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (1997), World Health Organization, Geneva, Switzerland WHO/NUT/NCD/98
41. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435